.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 7,150,881

« Back to Dashboard

Claims for Patent: 7,150,881

Title:Adhesive mixture for transdermal delivery of highly plasticizing drugs
Abstract:Transdermal drug delivery patches and methods of their production are described. The patches can be made such that the accommodate highly plasticizing drugs such as selegiline and/or the use of protonated forms of various drugs.
Inventor(s): Govil; Sharad K. (Essex, VT), Weimann; Ludwig J. (Burlington, VT)
Assignee: Mylan Technologies, Inc. (St. Albans, VT)
Application Number:08/883,075
Patent Claims: 1. A transdermal delivery system which has been dried at a predetermined processing temperature consisting essentially of a blend of: (a) one or more hydrophobic acrylic polymers; and (b) a therapeutically effective amount of one or more drugs, at least one of which is of low molecular weight and liquid at or about room temperatures, wherein said system is substantially free of both water and liquids other than said at least one drug having a boiling point (i) below said predetermined processing temperature and (ii) equal to or greater than the boiling points of the low molecular weight drugs.

2. The transdermal delivery system of claim 1 wherein said acrylic polymers include a C.sub.4 C.sub.12 alkyl acrylate.

3. The transdermal delivery system of claim 2 wherein said acrylic polymers include a C.sub.1 C.sub.4 alkyl acrylate hardening monomer.

4. The transdermal delivery system of claim 3 wherein said acrylic polymers include a functionalizing monomer.

5. The transdermal delivery system of claim 4 wherein said acrylic polymers include a cross-linking agent.

6. The transdermal delivery system of claim 1 wherein said at least one of said one or more drugs has a molecular weight of less than about 300 MW.

7. The transdermal delivery system of claim 1 including from about 3% to 35% of said therapeutically effective amount of one or more drugs.

8. A transdermal delivery system which has been dried at a predetermined processing temperature consisting essentially of a blend of: (a) a hydrophobic acrylic polymer; and (b) a therapeutically effective amount of a drug having a low molecular weight and being a liquid at or about room temperature, wherein said system is substantially free of both water and liquids other than said drug having a boiling point (i) below processing temperature and (ii) equal to or greater than the boiling points of the low molecular weight drug, whereby said transdermal drug delivery system, subsequent to processing, is free of said water and liquids other than said drug.

9. The transdermal delivery system of claim 1 wherein said at least one of said one or more drugs comprises selegiline.

10. The transdermal delivery system of claim 8 wherein said drug comprises selegiline.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc